Key facts
- This page summarizes Albert Bourla's Form 4 filing for PFIZER INC (PFE).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 28 Feb 2024, 16:59.
Albert Bourla - 27 Feb 2024 Form 4 Insider Report for PFIZER INC (PFE)
- Reporting relationship
- Chairman & CEO, Director
- Issuer ticker
- PFE
- Reported as of
- 27 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Feb 2024, 16:59:57 UTC
- Prior SEC filing
- 27 Feb 2024
- Next SEC filing
- 05 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- Susan E. Grant, by power of atty., for Albert Bourla
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Albert Bourla filed Form 4 for PFIZER INC (PFE) on 28 Feb 2024.
Change
- Previous filing in this sequence was filed on 27 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PFE
transaction
Derivative
Stock Appreciation Rights
Award
- Transaction value
- $0
- Shares
- +644,640
- Change %
- Price
- $0.000000
- Shares after
- 644,640
- Date
- 27 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 644,640
- Exercise price
- $26.89
- Footnotes
- F1
PFE
transaction
Derivative
Stock Appreciation Rights
Award
- Transaction value
- $0
- Shares
- +569,600
- Change %
- Price
- $0.000000
- Shares after
- 569,600
- Date
- 27 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 569,600
- Exercise price
- $26.89
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
Footnote F2
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.